The review found no eligible studies for this question.
Single‐dose, preoperative MMC‐EMDA probably leads to lower time to recurrence compared with TURBT alone (moderate certainty).
It is very uncertain whether single‐dose, preoperative MMC‐EMDA changes time to progression compared with TURBT alone (very low certainty).
It is very uncertain whether single‐dose, preoperative MMC‐EMDA changes serious adverse events compared with TURBT alone (very low certainty).
Single‐dose, preoperative MMC‐EMDA showed no clear difference in disease‐specific survival compared with TURBT alone (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether postoperative MMC‐EMDA induction changes serious adverse events compared with postoperative BCG induction therapy (very low certainty).
The review found no eligible studies for this question.
Postoperative MMC‐EMDA induction may leads to lower time to recurrence compared with MMC‐PD induction therapy (low certainty).
It is very uncertain whether postoperative MMC‐EMDA induction changes serious adverse events compared with MMC‐PD induction therapy (very low certainty).
Partial nephrectomy may leads to higher time‐to‐death of any cause (anticipated absolute effects refer to… compared with radical nephrectomy (low certainty).
Partial nephrectomy showed no clear difference in serious adverse events (Surgery‐related mortality) compared with radical nephrectomy (low certainty).
Partial nephrectomy showed no clear difference in time‐to‐recurrence (anticipated absolute effects refer to… compared with radical nephrectomy (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.